Point72 Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Point72 Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.13M	Buy	+114,006	New	+$3.9M	﹤0.01%	1892
2023 Q4	–	Sell	-952	Closed	-$21.3K	–	2257
2023 Q3	$21.3K	Buy	+952	New	+$21.7K	﹤0.01%	2284
2023 Q2	–	Sell	-1,795	Closed	-$43.1K	–	2254
2023 Q1	$43.1K	Buy	+1,795	New	+$47.6K	﹤0.01%	1813
2021 Q2	–	Sell	-133,522	Closed	-$3.16M	–	989
2021 Q1	$3.16M	Buy	+133,522	New	+$3.17M	0.01%	662
2017 Q1	–	Sell	-28,000	Closed	-$436K	–	827
2016 Q4	$436K	Buy	+28,000	New	+$465K	﹤0.01%	638

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Point72 Asset Management's COLL Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 114,006 shares worth $4.13M. The stake represents ﹤0.01% of the portfolio and ranks #1892 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in COLL as recently as Q3 2023.

Point72 Asset Management first reported a position in COLL in Q4 2016 and has held it in 5 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Point72 Asset Management held 114,006 shares of Collegium Pharmaceutical worth $4.13M as of Q2 2026.
Collegium Pharmaceutical was a new Point72 Asset Management position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1892 holding.
Point72 Asset Management first reported a position in Collegium Pharmaceutical in Q4 2016 and has held it in 5 quarters since.
280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.